Risk Factors Update Summary
- Dependence on key suppliers of raw materials poses risk of interruptions, especially due to stem cell shortage affecting future revenues.
- Enhanced cybersecurity measures in 2022 and 2023 to protect against network intrusions and phishing.
- Acquisitions in 2023 and future ones pose risks affecting business, reputation, and financial condition.
- Ownership by ROS and Royalty Opportunities decreased from 67% to 56.2% in 2023.
- Integration of acquired products may not be well-received, impacting operations and financial condition.
- Issued approximately 20.3 million shares of common stock at $0.48 per share in 2023.
- Identified material weaknesses in internal control over financial reporting may impact financial condition.
- Operations in unstable international markets expose the company to additional risks.
- Reliance on third-party suppliers for products and materials poses risks of interruptions and increased costs.
- Revenue dependence on independent sales agents and distributors outside the company's control poses risks.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1453593&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.